🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
30 Servings
Non-Nutrient/Non-Botanical Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

Bladderwrack (Fucus vesiculosus) extract
250 mg
📊 Market median: 80.0mg (20 products) 📚 334 studies (Tier A: 8, B: 183)
This product: 50mg

Other Ingredients

Hydroxypropyl Methylcellulose L-Leucine Silicon Dioxide Microcrystalline Cellulose

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (91% of products) Nutrient (14% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested use As a dietary supplement, 1 capsule daily, or as directed by a healthcare practitioner. May be taken with or without food.

⚠️ Warnings & Precautions

Warning: Not intended for use by children, or by pregnant or lactating women.

Warning: Not intended for use by children, or by pregnant or lactating women.

Contains: Milk (in trace amounts)

🧪 Formulation Notes

Fucco-Immune contains Maritech Synergy, a fucoidan seaweed extract, and heat-treated L. plantarum L-137 (Immuno-LP20), a stable immunobiotic. Together they support healthy lung and respiratory function, healthy gut lining and gut immunity, and antioxidant activity.

With Immuno-LP20 & Maritech Synergy Fucoidan

Contains: Milk (in trace amounts)

Immuno-LP20

Additional Information

Store in a cool, dry place, tightly capped. Best refrigerated for long term storage.

Product Details

UPC / SKU 7 13947 77150 5
DSLD Entry Date 2019-11-21
Product Type Non-Nutrient/Non-Botanical
Form Capsule
DSLD ID 207908
Data Updated 2026-04-11

Research Evidence

691 Research Sources
52 Avg Quality Score
255 Clinical Trial
205 Meta Analysis
123 Rct
81 Systematic Review
18 Cochrane Review
2 Guideline
2 Regulatory Source
1 Other
1 Narrative Review
1 Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019
View all evidence for Probiotics →

Compare Similar Products

View all Probiotics products →